Published: 20th Apr, 2020
Context:
- An Australian company has called out for volunteers in the country’s first human trial of a COVID-19 vaccine, expected to take place in coming weeks.
- Clinical Research Company Nucleus Network revealed that it would test the effectiveness and safety of a Recombinant Spike Protein Nanoparticle vaccine, NVX-CoV2373, developed by US based biotechnology company Novavax, reports Xinhua news agency.
- It would take roughly 12-18 months from now before the vaccine could be released to the public.
- There was absolutely no chance that the volunteers could be infected with the disease by taking part.
- The World Health Organization estimated at least 20 other COVID-19 candidate vaccines are in development around the world.
Courses
Study
Notes
Home
Resources
More
